Variable expression of activation-linked surface antigens on human mast cells in health and disease

Authors: Valent, P.1; Schernthaner G.-H.,1; Sperr, W.R.1; Fritsch, G.2; Agis, H.1; Willheim, M.3; Bühring H.-J.,4; Orfao, A.5; Escribano, L.6

Source: Immunological Reviews, Volume 179, Number 1, 1 February 2001 , pp. 74-81(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

Summary:

Mast cells (MC) are multipotent effector cells of the immune system. They contain an array of biologically active mediator substances in their granules. MC also express a number of functionally important cell surface antigens, including stem cell factor receptor (SCFR=kit=CD117), high affinity IgER (FcεRI), or C5aR (CD88). Respective ligands can induce or promote degranulation, migration, or cytokine production. Other integral surface molecules can mediate adhesion or cell aggregation. Recent data suggest that a number of critical molecules are variably expressed on the surface of human MC. In fact, depending on the environment (organ), stage of cell maturation, type of disease, and other factors, MC express variable amounts of activation-linked antigens (CD25, CD63, CD69, CD88), cell recognition molecules (CD2, CD11, CD18, CD50, CD54), or cytokine receptors. At present, however, little is known about the mechanisms and regulation of expression of such antigens. The present article gives an overview of MC phenotypes in health and disease, and attempts to provide explanations for the phenotypic variability of MC.

Document Type: Original article

Affiliations: 1: Department of Internal Medicine I, Division of Hematology & Hemostaseology, University of Vienna, Austria. 2: St. Anna Children's Hospital, Vienna, Austria. 3: Institute of Pathophysiology, University of Vienna, Austria. 4: Department of Internal Medicine II, University of Tübingen, Germany. 5: Servicio Central de Citometría, Centro de Investigación del Cancer, Universidad de Salamanca, Madrid, Spain. 6: Servicio de Hematologia, Mast Cell Unit, Hospital Ramón y Cajal, University of Alcalá de Henares, Madrid, Spain.

Publication date: 2001-02-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page